Expert review of anti-infective therapy

Keyphrases

Publications

volume 21, number 3, 2023

Ashfaq Ahmad, Zhandaulet Makhmutova, Wenwen Cao, Sidra Majaz, Amr Amin, Yingqiu Xie
Androgen receptor, a possible anti-infective therapy target and a potent immune respondent in SARS-CoV-2 spike binding: a computational approach. Expert review of anti-infective therapy 21 (3) (2023)
Paul Feuerstadt
Where does RBX2660 fit within clinical practice? Expert review of anti-infective therapy 21 (3) (2023)
Wenjing Ji, Ali Hassan Gillani, Dan Ye, Hang Zhao, Jiaxi Du, David J McIver, Yun Tian
Perceptions and preparedness of senior medical students about antimicrobial stewardship programs: are we providing adequate training to future prescribers? Expert review of anti-infective therapy 21 (3) (2023)
Cristina García de la Mària, Maria-Alexandra Cañas, Mariana Fernández-Pittol, Anders Dahl, Javier García-González, Marta Hernández-Meneses, Guillermo Cuervo, Asunción Moreno, Jose M Miró, Francesc Marco
Emerging issues on Staphylococcus aureus endocarditis and the role in therapy of daptomycin plus fosfomycin. Expert review of anti-infective therapy 21 (3) (2023)
Arsha Khari, Biswambhar Biswas, Garima Gangwar, Anil Thakur, Rekha Puria
Candida auris biofilm: a review on model to mechanism conservation. Expert review of anti-infective therapy 21 (3) (2023)
Caleb P Skipper, Mark R Schleiss
Cytomegalovirus viremia and advanced HIV disease: is there an argument for anti-CMV treatment? Expert review of anti-infective therapy 21 (3) (2023)
Teena Chopra
A profile of the live biotherapeutic product RBX2660 and its role in preventing recurrent Clostridioides difficile infection. Expert review of anti-infective therapy 21 (3) (2023)
Arsha Khari, Biswambhar Biswas, Garima Gangwar, Anil Thakur, Rekha Puria
Candida auris biofilm: a review on model to mechanism conservation. Expert review of anti-infective therapy 21 (3) (2023)
Wenjing Ji, Ali Hassan Gillani, Dan Ye, Hang Zhao, Jiaxi Du, David J McIver, Yun Tian
Perceptions and preparedness of senior medical students about antimicrobial stewardship programs: are we providing adequate training to future prescribers? Expert review of anti-infective therapy 21 (3) (2023)
Cristina García de la Mària, Maria-Alexandra Cañas, Mariana Fernández-Pittol, Anders Dahl, Javier García-González, Marta Hernández-Meneses, Guillermo Cuervo, Asunción Moreno, Jose M Miró, Francesc Marco
Emerging issues on Staphylococcus aureus endocarditis and the role in therapy of daptomycin plus fosfomycin. Expert review of anti-infective therapy 21 (3) (2023)
Caleb P Skipper, Mark R Schleiss
Cytomegalovirus viremia and advanced HIV disease: is there an argument for anti-CMV treatment? Expert review of anti-infective therapy 21 (3) (2023)
Teena Chopra
A profile of the live biotherapeutic product RBX2660 and its role in preventing recurrent Clostridioides difficile infection. Expert review of anti-infective therapy 21 (3) (2023)
George Sakoulas, Michael Nowak, Matthew Geriak
Omadacycline in treating community-based infections: a review and expert perspective. Expert review of anti-infective therapy 21 (3) (2023)
Coen T Butters, Karin A Thursky, Diane T Hanna, Theresa Cole, Andrew J Davidson, Jim P Buttery, Gabrielle M Haeusler
Adverse effects of antibiotics in children with cancer: are short-course antibiotics for febrile neutropenia part of the solution? Expert review of anti-infective therapy 21 (3) (2023)
Wenjing Ji, Ali Hassan Gillani, Dan Ye, Hang Zhao, Jiaxi Du, David J McIver, Yun Tian
Perceptions and preparedness of senior medical students about antimicrobial stewardship programs: are we providing adequate training to future prescribers? Expert review of anti-infective therapy 21 (3) (2023)

volume 21, number 4, 2023

Jorge Luis Costa Carvalho, Ekaterina Dadachova
Radioimmunotherapy for the treatment of infectious diseases: a comprehensive update. Expert review of anti-infective therapy 21 (4) (2023)
Abdollah Ardebili, Ahdieh Izanloo, Mostafa Rastegar
Polymyxin combination therapy for multidrug-resistant, extensively-drug resistant, and difficult-to-treat drug-resistant gram-negative infections: is it superior to polymyxin monotherapy? Expert review of anti-infective therapy 21 (4) (2023)
Lorenzo Volpicelli, Mario Venditti, Alessandra Oliva
Acute bacterial skin and skin structure infections in pediatric patients: potential role of dalbavancin. Expert review of anti-infective therapy 21 (4) (2023)
Jinliang Xie, Dingwei Liu, Jianxiang Peng, Shuang Wu, Dongsheng Liu, Yong Xie
Iatrogenic factors of Helicobacter pylori eradication failure: lessons from the frontline. Expert review of anti-infective therapy 21 (4) (2023)
Shiza Malik, Khalid Muhammad, Sanaa Masood Aslam, Yasir Waheed
Tracing the recent updates on vaccination approaches and significant adjuvants being developed against HIV. Expert review of anti-infective therapy 21 (4) (2023)
Johann Dd Pitout, Gisele Peirano, Rebekah DeVinney
The contributions of multidrug resistant clones to the success of pandemic extra-intestinal Pathogenic Escherichia coli . Expert review of anti-infective therapy 21 (4) (2023)
Mehran Alavi, Morahem Ashengroph
Mycosynthesis of AgNPs: mechanisms of nanoparticle formation and antimicrobial activities. Expert review of anti-infective therapy 21 (4) (2023)
Suhaib M Muflih, Sayer Al-Azzam, Reema A Karasneh, Barry A Bleidt, Barbara R Conway, Stuart E Bond, Mamoon A Aldeyab
Public knowledge of antibiotics, self-medication, and household disposal practices in Jordan. Expert review of anti-infective therapy 21 (4) (2023)
Jason Alexander Roberts, Katherine Croom, Nicholas Adomakoh
Continuous infusion of beta-lactam antibiotics: narrative review of systematic reviews, and implications for outpatient parenteral antibiotic therapy. Expert review of anti-infective therapy 21 (4) (2023)
Johann Dd Pitout, Gisele Peirano, Rebekah DeVinney
The contributions of multidrug resistant clones to the success of pandemic extra-intestinal Pathogenic Escherichia coli . Expert review of anti-infective therapy 21 (4) (2023)
Suhaib M Muflih, Sayer Al-Azzam, Reema A Karasneh, Barry A Bleidt, Barbara R Conway, Stuart E Bond, Mamoon A Aldeyab
Public knowledge of antibiotics, self-medication, and household disposal practices in Jordan. Expert review of anti-infective therapy 21 (4) (2023)
Abdollah Ardebili, Ahdieh Izanloo, Mostafa Rastegar
Polymyxin combination therapy for multidrug-resistant, extensively-drug resistant, and difficult-to-treat drug-resistant gram-negative infections: is it superior to polymyxin monotherapy? Expert review of anti-infective therapy 21 (4) (2023)
Amanj Baker Kurdi, Niketa Platt, Aidan Morrison, Euan Proud, Karen Gronkowski, Tanja Mueller, R Andrew Seaton, William Malcolm, Marion Bennie
Evaluation of duration of antibiotic therapy across hospitals in Scotland including the impact of COVID-19 pandemic: a segmented interrupted time series analysis. Expert review of anti-infective therapy 21 (4) (2023)
Shiza Malik, Khalid Muhammad, Sanaa Masood Aslam, Yasir Waheed
Tracing the recent updates on vaccination approaches and significant adjuvants being developed against HIV. Expert review of anti-infective therapy 21 (4) (2023)
Amanj Baker Kurdi, Niketa Platt, Aidan Morrison, Euan Proud, Karen Gronkowski, Tanja Mueller, R Andrew Seaton, William Malcolm, Marion Bennie
Evaluation of duration of antibiotic therapy across hospitals in Scotland including the impact of COVID-19 pandemic: a segmented interrupted time series analysis. Expert review of anti-infective therapy 21 (4) (2023)
Lorenzo Volpicelli, Mario Venditti, Alessandra Oliva
Acute bacterial skin and skin structure infections in pediatric patients: potential role of dalbavancin. Expert review of anti-infective therapy 21 (4) (2023)
Mehran Alavi, Morahem Ashengroph
Mycosynthesis of AgNPs: mechanisms of nanoparticle formation and antimicrobial activities. Expert review of anti-infective therapy 21 (4) (2023)
Jorge Luis Costa Carvalho, Ekaterina Dadachova
Radioimmunotherapy for the treatment of infectious diseases: a comprehensive update. Expert review of anti-infective therapy 21 (4) (2023)
Jinliang Xie, Dingwei Liu, Jianxiang Peng, Shuang Wu, Dongsheng Liu, Yong Xie
Iatrogenic factors of Helicobacter pylori eradication failure: lessons from the frontline. Expert review of anti-infective therapy 21 (4) (2023)
Jason Alexander Roberts, Katherine Croom, Nicholas Adomakoh
Continuous infusion of beta-lactam antibiotics: narrative review of systematic reviews, and implications for outpatient parenteral antibiotic therapy. Expert review of anti-infective therapy 21 (4) (2023)

volume 21, number 5, 2023

Rana E El Feghaly, Amanda Nedved, Sophie E Katz, Holly M Frost
New insights into the treatment of acute otitis media. Expert review of anti-infective therapy 21 (5) (2023)
Teena Chopra
Women in anti-infectives: foreword. Expert review of anti-infective therapy 21 (5) (2023)
Zoe Freeman Weiss, Jessica S Little, Sarah P Hammond
Evolution of antifungals for invasive mold infections in immunocompromised hosts, then and now. Expert review of anti-infective therapy 21 (5) (2023)
Zoe Freeman Weiss, Jessica S Little, Sarah P Hammond
Evolution of antifungals for invasive mold infections in immunocompromised hosts, then and now. Expert review of anti-infective therapy 21 (5) (2023)
Teena Chopra
Women in anti-infectives: foreword. Expert review of anti-infective therapy 21 (5) (2023)
Rana E El Feghaly, Amanda Nedved, Sophie E Katz, Holly M Frost
New insights into the treatment of acute otitis media. Expert review of anti-infective therapy 21 (5) (2023)
Zoe Freeman Weiss, Jessica S Little, Sarah P Hammond
Evolution of antifungals for invasive mold infections in immunocompromised hosts, then and now. Expert review of anti-infective therapy 21 (5) (2023)
Teena Chopra
Women in anti-infectives: foreword. Expert review of anti-infective therapy 21 (5) (2023)
Zoe Freeman Weiss, Jessica S Little, Sarah P Hammond
Evolution of antifungals for invasive mold infections in immunocompromised hosts, then and now. Expert review of anti-infective therapy 21 (5) (2023)
Rana E El Feghaly, Amanda Nedved, Sophie E Katz, Holly M Frost
New insights into the treatment of acute otitis media. Expert review of anti-infective therapy 21 (5) (2023)
Rana E El Feghaly, Amanda Nedved, Sophie E Katz, Holly M Frost
New insights into the treatment of acute otitis media. Expert review of anti-infective therapy 21 (5) (2023)
Teena Chopra
Women in anti-infectives: foreword. Expert review of anti-infective therapy 21 (5) (2023)

volume 21, number 6, 2023

Amir Hossein Miri, Mojtaba Kamankesh, Mazda Rad-Malekshahi, Abbas Yadegar, Maryam Banar, Michael Richard Hamblin, Ismaeil Haririan, Hamid Asadzadeh Aghdaei, Mohammad Reza Zali
Factors associated with treatment failure, and possible applications of probiotic bacteria in the arsenal against Helicobacter pylori . Expert review of anti-infective therapy 21 (6) (2023)
Nikil Selvaraj, Shreya Shyam, Puvin Dhurairaj, Kaviarasan Thiruselvan, Akil Thiruselvan, Yochana Kancherla, Pritika Kandamaran
Mpox: epidemiology, clinical manifestations and recent developments in treatment and prevention. Expert review of anti-infective therapy 21 (6) (2023)
Daniel S Graciaa, Marcos Coutinho Schechter, Krystle B Fetalvero, Lisa Marie Cranmer, Russell R Kempker, Kenneth G Castro
Updated considerations in the diagnosis and management of tuberculosis infection and disease: integrating the latest evidence-based strategies. Expert review of anti-infective therapy 21 (6) (2023)